<DOC>
	<DOCNO>NCT01205984</DOCNO>
	<brief_summary>The place systemic corticosteroid treatment child chronic rhinosinusitis ( CRS ) remain unclear . We aim assess effectiveness tolerability oral methylprednisolone ( MP ) anti-inflammatory adjunct treatment CRS children.Forty-eight child ( age 6-17 year ) clinically radiologically proven CRS include . Patients randomly assign either oral amoxicillin/clavulanate ( AMX/C ) MP AMX/C placebo ( P ) twice daily 30 day . Oral MP administer first 15 day taper schedule . Primary parameter mean change symptom sinus compute tomography ( CT ) scan score treatment . Secondary study parameter mean change individual symptom score treatment , relapse rate tolerability . Forty-five patient complete study , 22 receive AMX/C MP , 23 AMX/C P. Both group demonstrate significant improvement symptom sinus CT score , compare baseline end treatment ( p &lt; 0.001 ) . Methylprednisolone adjunct significantly effective placebo reduce CT score ( p=0.004 ) , total rhinosinusitis symptom ( p=0.001 ) individual symptom nasal obstruction ( p=0.001 ) , postnasal discharge ( p=0.007 ) , cough ( p=0.009 ) . At end treatment , 48 % child P group still abnormal finding CT versus 14 % MP group ( p = 0.013 ) . Therapy-related adverse event different group . Although insignificant , incidence clinical relapse also less MP group ( 25 % ) compare P group ( 43 % ) ( p = 0.137 ) . Oral MP well tolerate provide added benefit treatment antibiotic child CRS .</brief_summary>
	<brief_title>Systemic Methylprednisolone Chronic Rhinosinusitis</brief_title>
	<detailed_description />
	<mesh_term>Sinusitis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>All patient present nasal and/or postnasal purulence , one follow symptom : nasal obstruction , cough , halitosis , headache , facial pain/pressure . The diagnosis CRS make basis sinonasal symptom sign present period 3 month presence abnormality coronal sinus CT scan . Patients exclude used systemic corticosteroid last 2 month prior study , systemic antibiotic inhaler intranasal corticosteroid last 4 week prior study respiratory disorder ( cystic fibrosis , ciliary dyskinesia , nasal polyp , large adenoid , asthma ) , immune deficiency , systemic disease , gastroesophageal reflux , aspirin sensitivity , acquire congenital sinonasal abnormality , contraindication corticosteroid use .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Chronic rhinosinusitis</keyword>
	<keyword>Computed tomography scan</keyword>
	<keyword>Methylprednisolone</keyword>
</DOC>